Major Autism Research Results Astonish The Science Community

PaxMedica's Groundbreaking Phase 2 Study Results on Autism Spectrum Disorder: A Leap Forward in Pediatric Neurodevelopmental Disorders.

Disclaimer: This post includes information about PaxMedica, a company in which the author has no ownership or affiliate interests, and receives no payment or material support.

In a major breakthrough for pediatric neurodevelopmental disorders, PaxMedica (PXMD) recently announced the publication of its Autism Spectrum Disorder (ASD) Phase 2 study results …